CMS Transmittal R13945MPI: Updates to Chapter 3, Chapter 4, and Chapter 5 in Publication (Pub.) 100-15, Including Updates…
Medicaid
CPT procedure code
19499
Medicare payment
—
No national Medicare fee schedule we hold prices 19499 — the Physician Fee Schedule lists it with status indicator C (2026 file). CMS fee schedules ↗
Code definition
Code
19499
Code system
CPT (Current Procedural Terminology)
This CPT code is not in our curated reference. CPT codes are maintained by the American Medical Association (AMA). Full descriptions require an AMA license.
Category
—
Short description sourced from CMS publicly available fee schedule data. Full CPT descriptions are copyright AMA. Not a substitute for the official CPT codebook.
Latest reimbursement alerts
No policy changes are currently matched to 19499. Here are the latest changes across all codes.
High
FDA Approval: RASONQUE (DARAXONRASIB) — Type 1 - New Molecular Entity
Oncology
FDA Approval: VOBRIG (LEUPROLIDE ACETATE) — Type 5 - New Formulation or New Manufacturer
Oncology
FDA Approval: NDA 220106 — Type 1 - New Molecular Entity
Multi-specialty
FDA Approval: BIXLENVO (BICTEGRAVIR/LENACAPAVIR) — Type 4 - New Combination
Infectious Disease
FDA Approval: NDA 221443 — Type 4 - New Combination
Multi-specialty
Audit documentation
Building an audit file that includes CPT 19499?
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
See audit packs — $349One-time purchase · not a subscription
Get alerts when policy changes affect 19499
Free weekly digest — no subscription required.
Look up another code
Search ICD-10, HCPCS, or CPT codes with related reimbursement alerts.